Bio/Pharma News

Oct 01, 2018
By Pharmaceutical Technology Editors
The divestiture of the European generic-drug business of Sanofi—Zentiva—to Advent International has been completed.
Oct 01, 2018
By Pharmaceutical Technology Editors
The companies partnered to build a 500-L single-use pilot-scale plant for biologics production.
Oct 01, 2018
By Pharmaceutical Technology Editors
Kangstem Biotech has selected Orgenesis subsidiary, MaSTherCell, as its contract manufacturing partner for the European clinical trial of Furestem-AD.
Sep 27, 2018
By Pharmaceutical Technology Editors
The company plans to lay off approximately 400 employees to support the restructuring of its R&D organization.
Sep 27, 2018
By Pharmaceutical Technology Editors
The company’s biosimiliar to Amgen’s Neulasta (pegfilgrastim) received a positive opinion for marketing authorization from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).
Sep 26, 2018
The European Medicines Agency’s detection of a second nitrosamine in a sartan API is driving a deeper dive into tetrazole chemistry; root-cause investigations will now include not only valsartan and losartan, but candesartan, irbesartan, and olmesartan.
Sep 24, 2018
By Pharmaceutical Technology Editors
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended 13 new medicines for approval, including three orphan drug candidates.
Sep 20, 2018
By Pharmaceutical Technology Editors
BeiGene is set to build late-stage clinical and commercial production capacity for cancer monoclonal antibodies with GE Healthcare’s KUBio, the prefabricated biopharma facility based on single-use technologies.
Sep 20, 2018
By Pharmaceutical Technology Editors
The company announced it is creating a new Primary Care global business unit and a China & Emerging Markets unit.
Sep 20, 2018
By Pharmaceutical Technology Editors
The agency will review Praluent (alirocumab) Injection, a PCSK9 inhibitor, as a possible treatment of cardiovascular events.
native1_300x100
lorem ipsum